33 related articles for article (PubMed ID: 11441080)
1. Immunity against mouse thymus-leukemia antigen (TL) protects against development of lymphomas induced by a chemical carcinogen, N-butyl-N-nitrosourea.
Tsujimura K; Obata Y; Matsudaira Y; Ozeki S; Taguchi O; Nishida K; Okanami Y; Akatsuka Y; Kuzushima K; Takahashi T
Cancer Sci; 2004 Nov; 95(11):914-9. PubMed ID: 15546510
[TBL] [Abstract][Full Text] [Related]
2. Development, Homeostasis, and Functions of Intestinal Intraepithelial Lymphocytes.
Van Kaer L; Olivares-Villagómez D
J Immunol; 2018 Apr; 200(7):2235-2244. PubMed ID: 29555677
[TBL] [Abstract][Full Text] [Related]
3. The role of MHC class Ib-restricted T cells during infection.
Anderson CK; Brossay L
Immunogenetics; 2016 Aug; 68(8):677-91. PubMed ID: 27368413
[TBL] [Abstract][Full Text] [Related]
4. Differential remodeling of a T-cell transcriptome following CD8- versus CD3-induced signaling.
Abidi SH; Dong T; Vuong MT; Sreenu VB; Rowland-Jones SL; Evans EJ; Davis SJ
Cell Res; 2008 Jun; 18(6):641-8. PubMed ID: 18475290
[TBL] [Abstract][Full Text] [Related]
5. Intraepithelial lymphocytes and their recognition of non-classical MHC molecules.
Blumberg RS; Balk SP
Int Rev Immunol; 1994; 11(1):15-30. PubMed ID: 7520051
[TBL] [Abstract][Full Text] [Related]
6. The epitope detected by cytotoxic T lymphocytes against thymus leukemia (TL) antigen is TAP independent.
Tsujimura K; Obata Y; Iwase S; Matsudaira Y; Ozeki S; Takahashi T
Int Immunol; 2000 Sep; 12(9):1217-25. PubMed ID: 10967016
[TBL] [Abstract][Full Text] [Related]
7. Thymus-leukemia antigen (TL) as a major histocompatibility complex (MHC) class Ib molecule and tumor-specific antigen.
Tsujimura K; Obata Y; Takahashi T
Cancer Sci; 2004 Jun; 95(6):469-74. PubMed ID: 15182425
[TBL] [Abstract][Full Text] [Related]
8. Thymus leukemia antigen (TL)-specific cytotoxic T lymphocytes recognize the alpha1/alpha2 domain of TL free from antigenic peptides.
Tsujimura K; Obata Y; Kondo E; Nishida K; Matsudaira Y; Akatsuka Y; Kuzushima K; Takahashi T
Int Immunol; 2003 Nov; 15(11):1319-26. PubMed ID: 14565930
[TBL] [Abstract][Full Text] [Related]
9. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements.
Tsujimura K; Takahashi T; Iwase S; Matsudaira Y; Kaneko Y; Yagita H; Obata Y
J Immunol; 1998 Jun; 160(11):5253-61. PubMed ID: 9605121
[TBL] [Abstract][Full Text] [Related]
10. Positive selection of gamma delta CTL by TL antigen expressed in the thymus.
Tsujimura K; Takahashi T; Morita A; Hasegawa-Nishiwaki H; Iwase S; Obata Y
J Exp Med; 1996 Dec; 184(6):2175-84. PubMed ID: 8976173
[TBL] [Abstract][Full Text] [Related]
11. The binding of thymus leukemia (TL) antigen tetramers to normal intestinal intraepithelial lymphocytes and thymocytes.
Tsujimura K; Obata Y; Matsudaira Y; Ozeki S; Yoshikawa K; Saga S; Takahashi T
J Immunol; 2001 Jul; 167(2):759-64. PubMed ID: 11441080
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
